BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.80
+0.45 (1.35%)
Jul 24, 2025, 11:56 AM CST
1.35%
Market Cap854.16M
Revenue (ttm)304.65M
Net Income (ttm)44.91M
Shares Out25.61M
EPS (ttm)1.75
PE Ratio19.06
Forward PEn/a
Dividend1.65 (4.95%)
Ex-Dividend DateAug 7, 2025
Volume2,000
Average Volume3,736
Open33.35
Previous Close33.35
Day's Range33.35 - 33.35
52-Week Range30.70 - 39.30
Beta0.11
RSI42.54
Earnings DateAug 4, 2025

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. provides bio-materials and surgical services in Taiwan and internationally. It breeds and produces SPF laboratory rats and mice, including outbreed stocks, inbreed strains, and immune deficient models, as well as offers special animal model services. The company also provides endotoxin detection, animal heath diagnostic, and serological kits, as well as biological indicators. In addition, it offers IVC systems and ventilated houses equipment; professional and automated animal watering systems; transponders; chlorine di... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 91
Stock Exchange Taipei Exchange
Ticker Symbol 6662
Full Company Profile

Financial Performance

In 2024, BioLASCO Taiwan's revenue was 292.50 million, an increase of 10.49% compared to the previous year's 264.72 million. Earnings were 44.03 million, a decrease of -11.49%.

Financial Statements

News

There is no news available yet.